Table 1.
miRNA | Gene locus
|
Target | Main effect of the target in hematopoiesis or oncogenesis | Value in diagnosis or differential diagnosis of ALL | |
---|---|---|---|---|---|
miRNA-223 | Xq12 | FOXO103 | FOXO represses tumor suppression genes, such as BIM, | Higher expression in the subset of adult T-cell ALL displaying myeloid features than the other subsets;66 downregulated in ALL compared with AML73,74 | |
LMO2104 | Trail, and Fas L, which induce apoptosis;103 LMO2 is a pro-oncogene in T-cells105,106 | ||||
Let-7b | 22q13 | HMGA107 | HMGA is oncogenic | Downregulated in ALL compared with AML73,74 | |
miRNA-128a | 2q21 | BMI-1108 | A gene regulates self-renewal of leukemic cells109 | Upregulated in ALL compared with AML;73,74 highly expressed in E2A/PBX1-positive cases60 | |
miRNA-196a | 17q21-22 | HOXB8110 ERG111 | HOXB8 and ERG increase cell survival and proliferation of progenitors110 | Downregulated in T-ALL compared with AML; high miRNA-196a expression is significantly associated with an early immunophenotype of T-ALL110 | |
miRNA-196b | 7p15, between HOXA9 and HOXA10110 | c-myc101 ERG111 | ERG and c-myc increase cell survival and proliferation of progenitors112 | Downregulated in B-cell ALL;113 upregulated in MLL-rearranged63 and other HOXA-activated ALLs114 | |
miRNA-125b-1 | 11q24 | May be Trp53inp1115 | Trp53inp1 is a proapoptotic gene116 | Upregulated in B-ALL with chromosomal translocation t(11; 14) (q24; q32)115 | |
miRNA-128-3p | Not clear | PHF6117 | Might be a tumor suppressor gene118 | Significantly higher expressed in ALL samples than in AML or normal samples63,73 | |
miRNA-148a | 7p15.2 | BIM, PTEN119 | BIM and PTEN are proapoptotic genes119 | Highly expressed in T-ALL cases60 | |
miRNA-151 | Chromosome: 8 | ITK, ZAP-7060 | ITK plays an important role in normal T-cell functions and in the pathophysiology of both autoimmune diseases and T-cell malignancies;120 ZAP-70 expression is associated with the E2A/PBX1 rearrangement121 | Downmodulated in T-ALL60 | |
miRNA-424 | Xq26.3 | NFI-A,122 VEGFR2123 | NFI-A modulates the differentiation of hematopoietic progenitors;124 VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex125 | Highly expressed in patients with T-ALL and down modulated in AMLs with NPM1mutA60,122 | |
miRNA-23a | 19p13.13 |
HOXB4126 BCR/ABL127 CXCL12128 |
HOXB4 is oncogenic;126 BCR/ABL is oncogenic;127 CXCL12 regulates the interaction between hematopoietic stem and progenitor cells and BM stromal cells128 |
Higher expressed in AML compared with ALL72,129 | |
miRNA-27a | 19p13.13 | 4-3-3θ130 | 4-3-3θ is antiapoptotic130 | Higher expressed in AML compared with ALL;72 downregulated in ALL compared with hematopoietic stem-progenitor cells130 | |
miRNA-221 | Xp11.3 | p27131 | p27 prevent cell-cycle progression from G1 to S phase131 | Higher expressed in AML compared with ALL72,132 |
Abbreviations: miRNA, microRNAs; ALL, acute lymphoblastic leukemia; AML, acute myeloblastic leukemia; BM, bone marrow.